The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Evidence also shows better immune response to virus among users of spray
The new facility will provide an important boost to vaccine capacity in Africa
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders
Subscribe To Our Newsletter & Stay Updated
